308 related articles for article (PubMed ID: 30824175)
1. The value of a health insurance database to conduct pharmacoepidemiological studies in oncology.
Conte C; Vaysse C; Bosco P; Noize P; Fourrier-Reglat A; Despas F; Lapeyre-Mestre M
Therapie; 2019 Apr; 74(2):279-288. PubMed ID: 30824175
[TBL] [Abstract][Full Text] [Related]
2. [Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): How to translate guidelines into practice].
de Germay S; Conte C; Micallef J; Bouquet E; Chouchana L; Lafaurie M; Pariente A;
Therapie; 2023; 78(6):691-703. PubMed ID: 36841652
[TBL] [Abstract][Full Text] [Related]
3. Value of a national administrative database to guide public decisions: From the système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France.
Tuppin P; Rudant J; Constantinou P; Gastaldi-Ménager C; Rachas A; de Roquefeuil L; Maura G; Caillol H; Tajahmady A; Coste J; Gissot C; Weill A; Fagot-Campagna A
Rev Epidemiol Sante Publique; 2017 Oct; 65 Suppl 4():S149-S167. PubMed ID: 28756037
[TBL] [Abstract][Full Text] [Related]
4. Empirical assessment of case-based methods for drug safety alert identification in the French National Healthcare System database (SNDS): Methodology of the ALCAPONE project.
Thurin NH; Lassalle R; Schuemie M; Pénichon M; Gagne JJ; Rassen JA; Benichou J; Weill A; Blin P; Moore N; Droz-Perroteau C
Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):993-1000. PubMed ID: 32133717
[TBL] [Abstract][Full Text] [Related]
5. Pharmacoepidemiology for oncology clinical practice: Foundations, state of the art and perspectives.
de Germay S; Berdaï D; Noize P
Therapie; 2022; 77(2):229-240. PubMed ID: 34973825
[TBL] [Abstract][Full Text] [Related]
6. Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies.
Palmaro A; Moulis G; Despas F; Dupouy J; Lapeyre-Mestre M
Fundam Clin Pharmacol; 2016 Dec; 30(6):616-624. PubMed ID: 27351637
[TBL] [Abstract][Full Text] [Related]
7. Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): How to translate guidelines into practice.
de Germay S; Conte C; Micallef J; Bouquet E; Chouchana L; Lafaurie M; Pariente A;
Therapie; 2023; 78(6):679-689. PubMed ID: 36841656
[TBL] [Abstract][Full Text] [Related]
8. Record linkage for pharmacoepidemiological studies in cancer patients.
Herk-Sukel MP; Lemmens VE; Poll-Franse LV; Herings RM; Coebergh JW
Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):94-103. PubMed ID: 21812067
[TBL] [Abstract][Full Text] [Related]
9. Interest of large electronic health care databases in addictovigilance: Lessons from 15 years of pharmacoepidemiological contribution.
Dupui M; Micallef J; Lapeyre-Mestre M
Therapie; 2019 Apr; 74(2):307-314. PubMed ID: 30798951
[TBL] [Abstract][Full Text] [Related]
10. The challenges of pharmacoepidemiology of orphan drugs in rare diseases.
Lapeyre-Mestre M
Therapie; 2020 Apr; 75(2):215-220. PubMed ID: 32164974
[TBL] [Abstract][Full Text] [Related]
11. Use of the French national health insurance information system for research in the field of mental health: Systematic review and perspectives.
Revet A; Moulis G; Raynaud JP; Bui E; Lapeyre-Mestre M
Fundam Clin Pharmacol; 2022 Feb; 36(1):16-34. PubMed ID: 33998708
[TBL] [Abstract][Full Text] [Related]
12. The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology.
Bezin J; Duong M; Lassalle R; Droz C; Pariente A; Blin P; Moore N
Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):954-962. PubMed ID: 28544284
[TBL] [Abstract][Full Text] [Related]
13. Successful linkage of French large-scale national registry populations to national reimbursement data: Improved data completeness and minimized loss to follow-up.
Didier R; Gouysse M; Eltchaninoff H; Le Breton H; Commeau P; Cayla G; Glatt N; Glatt B; Gabbas M; Tuppin P; Liepchitz L; Boussac M; Iung B; Gilard M
Arch Cardiovasc Dis; 2020; 113(8-9):534-541. PubMed ID: 32712203
[TBL] [Abstract][Full Text] [Related]
14. Pharmacoepidemiology resources in Ireland-an introduction to pharmacy claims data.
Sinnott SJ; Bennett K; Cahir C
Eur J Clin Pharmacol; 2017 Nov; 73(11):1449-1455. PubMed ID: 28819675
[TBL] [Abstract][Full Text] [Related]
15. How reimbursement databases can be used to support drug utilisation studies: example using the main French national health insurance system database.
Latry P; Molimard M; Bégaud B; Martin-Latry K
Eur J Clin Pharmacol; 2010 Jul; 66(7):743-8. PubMed ID: 20429000
[TBL] [Abstract][Full Text] [Related]
16. Linkage of mother-baby pairs in the German Pharmacoepidemiological Research Database.
Garbe E; Suling M; Kloss S; Lindemann C; Schmid U
Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):258-64. PubMed ID: 21351307
[TBL] [Abstract][Full Text] [Related]
17. Pharmacoepidemiology research: delivering evidence about drug safety and effectiveness in mental health.
Davis KAS; Farooq S; Hayes JF; John A; Lee W; MacCabe JH; McIntosh A; Osborn DPJ; Stewart RJ; Woelbert E
Lancet Psychiatry; 2020 Apr; 7(4):363-370. PubMed ID: 31780306
[TBL] [Abstract][Full Text] [Related]
18. The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review.
Wettermark B; Zoëga H; Furu K; Korhonen M; Hallas J; Nørgaard M; Almarsdottir A; Andersen M; Andersson Sundell K; Bergman U; Helin-Salmivaara A; Hoffmann M; Kieler H; Martikainen J; Mortensen M; Petzold M; Wallach-Kildemoes H; Wallin C; Sørensen H
Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):691-9. PubMed ID: 23703712
[TBL] [Abstract][Full Text] [Related]
19. A MiniReview of the use of hospital-based databases in observational inpatient studies of drugs.
Larsen MD; Cars T; Hallas J
Basic Clin Pharmacol Toxicol; 2013 Jan; 112(1):13-8. PubMed ID: 22901097
[TBL] [Abstract][Full Text] [Related]
20. A review of the Ghana National Health Insurance Scheme claims database: possibilities and limits for drug utilization research.
Ankrah D; Hallas J; Odei J; Asenso-Boadi F; Dsane-Selby L; Donneyong M
Basic Clin Pharmacol Toxicol; 2019 Jan; 124(1):18-27. PubMed ID: 30260590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]